Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02658279
Title Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

high grade glioma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Los Angeles Recruiting Los Angeles California 90095 United States Details
University of California San Francisco Active, not recruiting San Francisco California 94143 United States Details
University of Miami Recruiting Miami Florida United States Details
Massachusetts General Hospital Not yet recruiting Boston Massachusetts 02114 United States Details
Brigham and Women's Hospital Recruiting Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02115 United States Details
Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Monmouth Recruiting Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Recruiting Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack Recruiting Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Recruiting Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Memorial Sloan Kettering Nassau Recruiting Uniondale New York 11553 United States Details
Cleveland Clinic Not yet recruiting Cleveland Ohio 44195 United States Details
Md Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
University of Utah Recruiting Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field